StocksMediumUpdated•Originally published 4 November 2026•Updated 4 November 2026•
1 min read
ADMA Biologics Reports Adjusted EPS of $0.23 for Q3 2026
Key Facts
1ADMA Biologics reported adjusted earnings per share of $0.23 for the third quarter of 2026.
2The company's revenue reached $141.1 million during the third quarter.
ADMA Biologics reported adjusted earnings per share of $0.23 for the third quarter of 2026. Benzinga reported that the company's revenue reached $141.1 million during the same period.
ADMA closed at $11.11 on November 3, 2026, with the stock trading between a low of $10.7 and a high of $11.44 during that session.
Latest Updates · 1
- Notable·
Update: The company's results exceeded analyst estimates, with earnings per share coming in $0.03 higher than expected. Total revenue also surpassed analyst projections for the third quarter of 2026.